HYBRID EVENT: You can participate in person at Paris, France or Virtually from your home or work.

6th Edition of World Congress on Infectious Diseases

June 24-26, 2024 | Paris, France

June 24 -26, 2024 | Paris, France

Infection 2023

Speaker at Infection Conferences - Genevieve Inchauspe
Keynote Presentation (In-Person)
Genevieve Inchauspe, ImmunResQ Department, France

A famous milestone in the vaccine field has been the first successful vaccination against smallpox in 1798 by Edward Jenner. Using the vaccinia cowpox virus, Jenner was able to protect vaccinees from variola or smallpox. The Modified Virus Ankara (MVA) poxvirus strain has been on [....] » Read More

Speaker at Infectious Diseases Conference - Pietro Salvatori
Keynote Presentation (In-Person)
Pietro Salvatori, Private Practice, Italy

The severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic is a major health concern affecting socio-economic lives. As with other highly contagious diseases, it is of utmost importance to identify and treat the healthy carriers or positive asymptomatic subjects (P [....] » Read More

Speaker at Infection Conferences - Rickyle Christopher Balea
Oral Presentation (In-Person)
Rickyle Christopher Balea, The University of the Sunshine Coast, Australia

Zika virus (ZIKV) is a re-emerging flavivirus that poses a significant public health threat. ZIKV exhibits a wide array of non-vector borne human transmission routes, such as sexual transmission, transplacental transmission and blood transfusion. Detection and surveillance of ZIK [....] » Read More

Speaker at Infection Conference - Sara Sentre Domingo
Oral Presentation (In-Person)
Sara Sentre Domingo, CerTest Biotec, Spain

Background Malaria (or paludism), is a mosquito-borne parasitic disease caused by Plasmodium, is a leading cause of death and disease in many developing countries. The objective of this study was to determine the clinical performance of VIASURE Malaria Real Time PCR Detection Ki [....] » Read More

Speaker at Infection Conference - Susan Jack
Oral Presentation (In-Person)
Susan Jack, University of Otago, New Zealand

Invasive meningococcal disease is a severe disease caused by Neisseria meningitidis that can present as septicaemia or meningitis and may lead to disability or death.  Nasopharyngeal carriage of N. meningitidis may occur in up to 15% of the general population with a higher p [....] » Read More

Speaker at Infectious Diseases Conference - Mohammad Mir
Oral Presentation (In-Person)
Mohammad Mir, Western University of Health Sciences, United States

Viruses from different families in the order Bunyavirales contains highly contagious and deadly viruses, having no cure at present. For example, hantaviruses from the family Hantaviridae are negative stranded emerging RNA viruses and category A pathogens that cause serious illnes [....] » Read More

Speaker at Infectious Diseases Conferences - Walter Fabricio Silva Martins
Oral Presentation (In-Person)
Walter Fabricio Silva Martins, Liverpool School of Tropical Medicine, United Kingdom

Aedes aegypti is the most important vector of at least four fatal and/or debilitating arboviruses (dengue, chikungunya, yellow fever and Zika). Insecticide-based approaches remain the major intervention to minimize vector-borne disease burden across the diseases. In Brazil [....] » Read More

Speaker at Infectious Diseases Conference - Pietro Salvatori
Oral Presentation (In-Person)
Pietro Salvatori, Private Practice, Italy

Background: This study was designed to evaluate the efficacy and safety of nebulized ethanol (EtOH) in the treatment of COVID-19. Methods: A RCT of 99 symptomatic and RT-PCR-positive patients admitted to a hospital receiving Remdesevir-Dexamethasone was conducted. They were ra [....] » Read More

Speaker at Infectious Diseases Conferences - Patricia Marques Moralejo Bermudi
Oral Presentation (In-Person)
Patricia Marques Moralejo Bermudi, University of Sao Paulo, Brazil

Dengue is a neglected tropical disease. This arbovirus is an important public health problem and has a great economic impact, especially in emerging countries. Globally, the incidence of dengue has expanded abruptly in recent decades, potentially associated with climatic factors. [....] » Read More

Speaker at Infection Conference - Elena Hatalova
Oral Presentation (In-Person)
Elena Hatalova, Pavol Jozef Safarik University, Slovakia (Slovak Republic)

Blastocystis spp., Cryptosporidium spp., Giardia intestinalis and Microsporidia spp. are protozoan and fungal intestinal pathogens in immunocompromised individuals, causing symptomatic or asymptomatic infections, which are usually undiagnosed. Uremia in hemodialysis patients with [....] » Read More

Speaker at Infection Conferences - Saiema Ahmedi
Oral Presentation (In-Person)
Saiema Ahmedi, Jamia Millia Islamia, India

A major global problem is the severe toxicity of conventional antifungal medications and multidrug resistance. Investigation of new substances with outstanding therapeutic potential is necessary. In this work, the antifungal potential of limonene, a secondary metabolite present i [....] » Read More

Speaker at Infectious Diseases Conferences - Adela Ngwewondo
Oral Presentation (In-Person)
Adela Ngwewondo, Institute of Medical Research and Medicinal Plants Studies, Cameroon

Twenty diseases are recognized as neglected tropical diseases (NTDs) by World Health Assembly resolutions, including human filarial diseases. The end of NTDs is embedded within the Sustainable Development Goals for 2030, under target 3.3. Onchocerciasis afflicts approximately 20. [....] » Read More

Speaker at Infection Conference - Sara Sentre Domingo
Oral Presentation (In-Person)
Sara Sentre Domingo, CerTest Biotec, Spain

Background: The appearance of skin lesions of viral nature can be a symptom of infection or reactivation of the herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2), varicella zoster virus (VZV), T. pallidum or mpox virus infection. Given the ability of t [....] » Read More

Speaker at Infection Conference - Aws Sami Sulaiman Al-Farsi
Oral Presentation (In-Person)
Aws Sami Sulaiman Al-Farsi, Sultan Qaboos University, Oman

Objectives To study the burden, clinical and laboratory features and outcome of Human Parechoviruses (HPeVs) infection among children managed at a tertiary hospital in Oman. Methods: This is a retrospective study of children (< 18 years of age) with molecular proven HPeV in [....] » Read More

Speaker at Infection Conferences - M Esperanza Teresa-Rodrigo
Oral Presentation (In-Person)
M Esperanza Teresa-Rodrigo, CerTest Biotec, Spain

Background: In an increasingly globalized and interconnected world, the outbreak of an infectious disease in one country can become a worrying health emergency for the whole world. A recent example is the 2022 Mpox outbreak affecting multiple areas across the world. In this [....] » Read More

Speaker at Infectious Diseases Conferences - Mohsin Khared
Oral Presentation (In-Person)
Mohsin Khared, King Abdulaziz University, Saudi Arabia

Surgical site infections (SSI) are a significant cause of morbidity and mortality after surgery. Due to its high morbidity and mortality rates after open-heart surgery, sternal wound infection (SWI) is one of the most important consequences to avoid and manage. Staphylococcus spe [....] » Read More

Speaker at Infection Conference - Milda Pleckaityte
Oral Presentation (In-Person)
Milda Pleckaityte, Vilnius University, Lithuania

The incidence of invasive meningococcal disease (IMD) in Lithuania was among the highest in Europe during the past two decades reaching an average of 2.24 cases/100,000 population. The vast majority of IMD cases were caused by serogroup B meningococci. In 2018, the only four-comp [....] » Read More

Speaker at Infectious Diseases Conferences - Hany Sady Shokry Redah
Oral Presentation (In-Person)
Hany Sady Shokry Redah, Tampere University, Finland

Background: The complex interaction between malaria and undernutrition leads to increased mortality and morbidity rate among young children in malaria-endemic regions. Results from previous interventions suggest that improving nutritional status of young children may reduce [....] » Read More

Speaker at Infectious Diseases Conferences - Kathrin Weyer
Poster Presentation (In-Person)
Kathrin Weyer, Heel GmbH, Germany

Despite the introduction of vaccines and new anti-viral therapies, the COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to be a serious global public health crisis. The emergence of new viral variants that escape protection from [....] » Read More

Speaker at Infection Conference - Raquel Gardini Sanches Palasio
Poster Presentation (In-Person)
Raquel Gardini Sanches Palasio, University of Sao Paulo, Brazil

Chikungunya and Zika diseases are caused by viruses from the families Togaviridae and Flaviviridae, respectively. These diseases are subject to climate change, as temperature and precipitation variations can affect the survival, reproduction and distribution of the virus and its [....] » Read More

Speaker at Infectious Diseases Conference - Sheeba S Sawant
Poster Presentation (In-Person)
Sheeba S Sawant, University of Wolverhampton, United Kingdom

Background: Medicinal plants have drawn attention due to their antibacterial properties against several disease-causing bacteria. Plectranthus amboinicus has been studied to possess various biological properties that can be explored to attain new therapeutics to combat such disea [....] » Read More

Speaker at Infection Conferences - Michael Ansah
Poster Presentation (In-Person)
Michael Ansah, University of Wolverhampton, United Kingdom

Diabetic foot ulcer (DFU) infections caused by multidrug resistant (MDR) organisms cost approximately 1% of the annual NHS budget, mainly through pre/post op management of complications/amputations. The aim of this study is to investigate the potential of guanidino based compound [....] » Read More

Speaker at Infection Conference - Raquel Gardini Sanches Palasio
Poster Presentation (In-Person)
Raquel Gardini Sanches Palasio, University of Sao Paulo, Brazil

Chikungunya and Zika diseases are transmitted by the same vectors, Aedes aegypti and Ae. albopictus, and possibly the transmission is related to the same environmental and socioeconomic factors. In other words, a simultaneous space and time occurrence is expected. In addition, th [....] » Read More

Speaker at Infectious Diseases Conferences - Sheema Mir
Poster Presentation (In-Person)
Sheema Mir, Western University of Health Sciences, United States

The infectious disease diagnostics often depends on costly serological testing with poor sensitivity, low specificity, and long turnaround time. Here In this manuscript, we demonstrate the proof of the principle for simultaneous detection of two tickborne pathogens from a single [....] » Read More

Speaker at Infectious Diseases Conference - Jeng How Yang
Poster Presentation (In-Person)
Jeng How Yang, New Taipei Municipal TuCheng Hospital, Taiwan

Background: Cryptococcal meningitis (CM) is associated with high mortality. The relation between antifungal susceptibility and treatment outcomes is not well characterized. There is paucity of surveillance data of cerebrospinal fluid (CSF) isolates of cryptococcus investigated wi [....] » Read More

Speaker at Infectious Diseases Conferences - Dharanga Rumeshi Ratnayake
Poster Presentation (In-Person)
Dharanga Rumeshi Ratnayake, University of Wolverhampton, United Kingdom

In recent years, a rise in the number of contact lens users in the UK and worldwide coincided with an increased incidence of microbial keratitis. The aim of this study was to investigate the antimicrobial activities of polyhexamethylene guanidine (PHMG), polyaminopropyl biguanide [....] » Read More

Speaker at Infection Conferences - Rege Anna Marton
Poster Presentation (In-Person)
Rege Anna Marton, University of Veterinary Medicine, Hungary

The indiscriminate use of conventional antibiotics has contributed to the global spread of antibiotic resistance, therefore, there is an urgent demand to search for alternatives that can provide a novel antimicrobial mode of action. Finding a potential replacement is crucial for [....] » Read More

Speaker at Infectious Diseases Conference - Tafaani Khan
Poster Presentation (In-Person)
Tafaani Khan, Boston Medical Center, United States

This study evaluates the ecology of Streptococcus pneumoniae (SP) nasopharynx (NP) colonization in response to the pneumococcal conjugate vaccines, specifically 7- Valent Pneumococcal Conjugate Vaccine (2000-2009), 13-Valent Pneumococcal Conjugate Vaccine (2010-2023) and 20-Valen [....] » Read More

Speaker at Infection Conferences - Marina Nick
Poster Presentation (In-Person)
Marina Nick, Division of Medicine, UCL, United Kingdom

The 3 major classes of soil transmitted helminths (whipworm, hookworm and Ascaris) affect 1.5 billion people worldwide mostly in poor countries, where they have adverse effects on child development, nutrition, and the work capacity of adults. Although there are drugs effective on [....] » Read More

Speaker at Infection Conferences - Clara Fehrmann
Poster Presentation (In-Person)
Clara Fehrmann, SPRIM US LLC, United States

Objective: COVID-19, caused by a coronavirus, SARS-CoV-2, has been the cause of the global pandemic from 2020-2022.  Due to COVID-19’s novelty, there exist no validated patient reported outcome (PRO) tools that allow for proper evaluation of patient infection seve [....] » Read More

Speaker at Infectious Diseases Conferences - Anderson da Silva Rêgo
Poster Presentation (In-Person)
Anderson da Silva Rêgo, Nursing School of Coimbra, Portugal

Pressure ulcers (PUs) are characterized as localized defects in the skin or underlying soft tissue caused by shear, friction, or prolonged and unrelieved pressure on bony prominences. They present a significant global health challenge, with prevalence rates ranging from [....] » Read More

Speaker at Infection Conference - Alfonso Recordare
Keynote Presentation (In-Person)
Alfonso Recordare, Dell'Angelo Hospital, Italy

Difficult-to-treat infections have led to a renewed interest in phage therapy as adjunct to conventional surgical and antimicrobials treatments. Chronic bone infections are biofilm-related infections difficult to eradicate; in vitro data indicate that phages are active against bi [....] » Read More

Speaker at Infectious Diseases Conferences - Alfredo Berzal-Herranz
Keynote Presentation (Virtual)
Alfredo Berzal-Herranz, Instituto de Parasitologia y Biomedicina “Lopez-Neyra”, (IPBLN) CSIC, Spain

RNA viruses are a major threat to the human health. They are responsible for infections with high morbidity and mortality rates and an extraordinary socioeconomic burden. In the last decades, different RNA viruses have produced major outbreaks against which there were no efficien [....] » Read More

Speaker at Infection Conferences - Seki Masafumi
Keynote Presentation (Virtual)
Seki Masafumi, Saitama Medical University International Medical Center, Japan

Background: New antiviral agents for COVID-19, including molnupiravir for the oral treatment and sotrovimab as the monoclonal antibody for the intravenous treatment are currently authorized and available in addition to remdesivir for the intravenous treatment in Japan. Method [....] » Read More

Speaker at Infectious Diseases Conferences - Wayne Joseph Dimech
Keynote Presentation (Virtual)
Wayne Joseph Dimech, National Serology Reference Laboratory, Australia

Historically, testing for antibodies to infectious diseases was performed using biological assays such as haemagglutination inhibition or complement fixation.  In recent times, this testing has moved to binding assays, firstly microtitre plate enzyme immunoassays and then to [....] » Read More

Speaker at Infectious Diseases Conference - Giuseppe Joe Vincini
Keynote Presentation (Virtual)
Giuseppe Joe Vincini, National Serology Reference Laboratory, Australia

Historically, testing for antibodies to infectious diseases was performed using biological assays such as haemagglutination inhibition or complement fixation.  In recent times, this testing has moved to binding assays, firstly microtitre plate enzyme immunoassays and then to [....] » Read More

Speaker at Infectious Diseases Conferences - Gayatri Tripathi
Keynote Presentation (Virtual)
Gayatri Tripathi, ICAR-Central Institute of Fisheries Education, India

Diseases of microbial aetiology of economic significance have surfaced in the aquaculture sector leading to high mortality and economic losses for farmers. Various environmentfriendly remedial measures have been taken up as an alternative to antibiotics to control microbial disea [....] » Read More

Speaker at Infection Conference - Chunyang Li
Keynote Presentation (Virtual)
Chunyang Li, Jiangsu Academy of Agricultural Sciences, China

Infectious diseases are becoming a health burden, causing numerous hospitalisation cases and deaths and leading to global economic losses. The prevention and control of infectious diseases have become more important as a result of the COVID-19 pandemic. Traditional disinfection m [....] » Read More

Speaker at Infectious Diseases Conferences - Vijay Prabha
Keynote Presentation (Virtual)
Vijay Prabha, Panjab University, India

Bacterial infections in the genital tract are one of the causes of female infertility worldwide with a prevalence rate of 30–40 %. Infertility in these cases is generally recognized as a consequence of inflammation. Bacteria may lead to inflammation due to the presence of L [....] » Read More

Speaker at Infectious Diseases Conferences - Ranjan Ramasamy
Keynote Presentation (Virtual)
Ranjan Ramasamy, IDFISH Technology, United States

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly infectious RNA virus that was first identified in December 2019 in Wuhan, China. It is the pathogen responsible for the present coronavirus disease 2019 (COVID-19) pandemic. A large number of genetic var [....] » Read More

Speaker at Infection Conferences - Stephen Hsu
Keynote Presentation (Virtual)
Stephen Hsu, Augusta University, United States

Background: Severe Acute Respiratory Syndrome (SARS) coronavirus 2 (SARS-CoV-2) is responsible for the 2019 coronavirus epidemic (COVID-19). SARS-CoV-2 infection is associated with high mortality and morbidity worldwide. By Dec 1, 2022, over 643 million cases have been reported w [....] » Read More

Speaker at Infectious Diseases Conferences - Saurabh Chattopadhyay
Keynote Presentation (Virtual)
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States

Virus infection causes various types of diseases in humans, and the innate immune responses serve as the first line of defense against viruses. Virus infection causes rapid induction of antiviral and inflammatory genes in the infected cells, leading to the establishment of an ant [....] » Read More

Speaker at Infection Conference - James Greenan-Barrett
Oral Presentation (In-Person)
James Greenan-Barrett, University College London Hospital, United Kingdom

Background: Despite children and young people (CYP) having a low risk for severe COVID-19 outcomes, there is still a degree of uncertainty related to their risk in the context of immunodeficiency or immunosuppression, primarily due to significant reporting bias in most studies, a [....] » Read More

Speaker at Infection Conference - Jacek Z Kubiak
Oral Presentation (In-Person)
Jacek Z Kubiak, Wojskowy Instytut Medyczny - PIB, Poland

Early during 2020 COVID-19 pandemics the proportion of children vs. adults positive for SARS-CoV-2 in a RT-PCR test was shown to be lower in different countries. This suggested that children are more resistant to the novel infection than adults. Here we show that in Warsaw, Polan [....] » Read More

Speaker at Infectious Diseases Conference - Saleh Binmahfooz
Oral Presentation (In-Person)
Saleh Binmahfooz, King Abdulaziz University, Saudi Arabia

Introduction: Coronavirus disease 2019 (COVID-19) has become the most devastating public health issue in the entire world. The disease has been spreading internationally and has swept the world in a short period. It stated as a pandemic by the World Health Organization on March [....] » Read More

Speaker at Infectious Diseases Conferences - Mónika Madai
Oral Presentation (In-Person)
Mónika Madai, University of Pécs, Hungary

The COVID-19 pandemic has led to an increased interest in the study of IgY (Immunoglobulin Y) as a potential inhibitor of SARS-CoV-2, the causative agent of COVID-19. IgY is a type of antibody found in birds, and reptiles, and it is similar in structure and function to the mammal [....] » Read More

Speaker at Infection Conference - Gadissa Bedada Hundie
Oral Presentation (In-Person)
Gadissa Bedada Hundie, St. Paul’s Hospital Millennium Medical College, Ethiopia

Background Coronavirus disease 19 (COVID-19) pandemic has posed a challenge to the health sector, and frontline healthcare workers (HCWs) are at higher risk of getting the infection. However, there is a scarcity of data on vaccination and post-vaccine breakthrough infections i [....] » Read More

Speaker at Infectious Diseases Conference - Elfian Rachmawati
Oral Presentation (In-Person)
Elfian Rachmawati, Diponegoro University, Indonesia

Leptospirosis co-infection and the pathogenesis of SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) play a significant part in the emergence and progression of SARS-CoV-2 infection by enhancing the difficulty of identification, management, and outcome of COVID-19 well [....] » Read More

Speaker at Infection Conference - Philip John M Joves
Oral Presentation (In-Person)
Philip John M Joves, Adventist Medical Center Manila, Philippines

Background: Adherence to antiretroviral therapy (ART) reduces morbidity and mortality among people living with HIV (PLHIV) by suppression of viral replication, restoration and preservation of immune function. However, poor adherence with ART may lead to treatment failure and dea [....] » Read More

Speaker at Infection Conferences - M Esperanza Teresa-Rodrigo
Oral Presentation (In-Person)
M Esperanza Teresa-Rodrigo, CerTest Biotec, Spain

Background: Every year, Influenza A (FluA), Influenza B (FluB) and Respiratory Syncytial Virus (RSV) affect our communities and increase the number of patients in our health systems. Symptoms are similar to those of SARS-CoV-2, so diagnosis is essential to initiate an approp [....] » Read More

Speaker at Infectious Diseases Conferences - Magdalena Piatek
Oral Presentation (In-Person)
Magdalena Piatek, Maynooth University, Ireland

The antimicrobial activity of silver has long been established and is widely used clinically. The low toxicity and broad-spectrum activity of silver make it a promising candidate in the fight against resistant pathogens. N-heterocyclic carbenes (NHCs) constitute a versatile range [....] » Read More

Speaker at Infectious Diseases Conferences - Klemen Bohinc
Oral Presentation (In-Person)
Klemen Bohinc, Faculty of Health Sciences, Slovenia

The application of orthopedic implants in our body is associated with the possibility of infection. To have the infections under control interactions between microorganisms and implant surfaces needs to be understood. Therefore, in this presentation we consider the microbial adhe [....] » Read More

Speaker at Infectious Diseases Conferences - Huiyi Feng
Oral Presentation (In-Person)
Huiyi Feng, Shenzhen Tianyou Medical Institute, China

In recent years, the frequent outbreaks of infectious diseases such as SARS and COVID-19 infection have seriously threatened human life and health and socio-economic development. Since there is no specific medicine for virus infection in medicine so far, the medical community and [....] » Read More

Speaker at Infection Conferences - Weixi Shen
Oral Presentation (In-Person)
Weixi Shen, Shenzhen Tianyou Medical Institute, China

In recent years, the frequent outbreaks of infectious diseases such as SARS and COVID-19 infection have seriously threatened human life and health and socio-economic development. Since there is no specific medicine for virus infection in medicine so far, the medical community and [....] » Read More

Speaker at Infection Conference - Jairo Antonio Cardenas Londono
Oral Presentation (In-Person)
Jairo Antonio Cardenas Londono, Hospital Regional de Moniquirá, Colombia

Introduction: Moniquira is a small town in Colombia, with 20,800 inhabitants. The main economic activity is agriculture. Leptospirosis is a zoonotic disease related with contaminated water, animals, and poverty. The aim of this paper is to describe the clinical course of the dise [....] » Read More

Speaker at Infection Conferences - Ratna Ayu Cahaya Kusuma Dewi
Oral Presentation (In-Person)
Ratna Ayu Cahaya Kusuma Dewi, Diponegoro University, Indonesia

Background Tuberculous (TB) meningoencephalitis is a major global health problem and the most severe form of extrapulmonary TB with high mortality rate. In case Mycobacterium tuberculosis (MTB) is suspected as the etiology, early diagnosis and treatment with anti-tuberculosis dr [....] » Read More

Speaker at Infectious Diseases Conference - Bidhi Dhital
Oral Presentation (In-Person)
Bidhi Dhital, Charak Memorial Hospital Pvt. Ltd, Nepal

Acute encephalitis syndrome (AES) is defined as acute onset of fever and a change in mental status (including symptoms such as confusion, disorientation, coma or inability to talk) and/or new onset of seizures (excluding simple febrile seizures) in a person of any age at any time [....] » Read More

Speaker at Infection Conferences - Mohammad AL - Mamun
Oral Presentation (In-Person)
Mohammad AL - Mamun, Research Fellow & Biochemist (Clinical Pathology), Bangladesh

Antimicrobial resistance is a serious issue since, by 2050, it's predicted to cause up to 10 million deaths globally (1-3). The emergence of fatal bacterial strains that are drug-resistant has been attributed to a number of factors, including the overuse of antibiotics, the s [....] » Read More

Speaker at Infection Conferences - Musa N Corr
Oral Presentation (In-Person)
Musa N Corr, The Gambia Field Epidemiology Training Program, Banjul, Gambia

Background: In 2016, the United Nations General Assembly’s Political Declaration on Ending AIDS committed countries to the 90–90–90 targets, which aim to bring HIV testing and treatment to many people living with HIV by the end of 2020.  Globally as of 2019 [....] » Read More

Speaker at Infection Conference - Nai An Lai
Oral Presentation (Virtual)
Nai An Lai, Mater Health, Australia

Severe pneumonia is one of the most common causes of sepsis and respiratory failure requiring intensive care. Despite advances in diagnostic techniques, antimicrobial therapy, respiratory support and organ support modalities; mortality and morbidity of severe pneumonia remain sig [....] » Read More

Speaker at Infectious Diseases Conferences - Shuyun Liu
Oral Presentation (Virtual)
Shuyun Liu, Wenjiang District People's Hospital, China

Background: During the COVID-19 epidemic, depression of medical staff showed a worsening trend year by year [1]. Interns in clinical teaching bases who are also in the front line of the fight against the epidemic are more likely to have mental health problems due to the unfamilia [....] » Read More

Speaker at Infection Conference - Diana Gonzaga Ramos
Oral Presentation (Virtual)
Diana Gonzaga Ramos, Research Institute for Tropical Medicine, Philippines

Background: The initiation of anti-retroviral therapy (ART) effectively restores immune function and reduces HIV-related morbidity and mortality. However, virologic failure while on ART may lead to increased morbidity and compromised quality of life. The aim of this study was to [....] » Read More

Speaker at Infection Conferences - Maria Yvez Erika P. Ugale
Oral Presentation (Virtual)
Maria Yvez Erika P. Ugale, San Lazaro Hospital, Philippines

Introduction: The SARS-CoV-2 virus, the main causative agent of COVID 19 infection was first detected in the province of Hubei in Wuhan China in December of 2019 and has overwhelmed the capacity of the government and hospitals to provide healthcare services to cater to the growin [....] » Read More

Speaker at Infection Conferences - Rajaa Sulaiman Al Aamri
Oral Presentation (Virtual)
Rajaa Sulaiman Al Aamri, Ministry of health, Oman

Aim of study: Group B streptococcus (GBS) is a leading cause of invasive infection among neonates and infants worldwide, with two described syndromes, early onset GBS (EOGBS) disease and late onset GBS (LOGBS) disease. In our study, we investigated the incidence of invasive GBS [....] » Read More

Speaker at Infection Conferences - Georgios D. Theodorakopoulos
Oral Presentation (Virtual)
Georgios D. Theodorakopoulos, Queen Margaret University, Greece

The last 2 years after breakout of Covid pandemic there have been reported and published skin integrity complications mostly in critical care departments covid infected patients. International literature highlights the spread per 57% of facial pressure ulcer development, as conse [....] » Read More

Speaker at Infection Conference - Jaime David Acosta Espana
Oral Presentation (Virtual)
Jaime David Acosta Espana, University of Jena, Germany

Mucormycosis is a fungal infection caused by members of the order Mucorales, the most prominent group among zygosporic fungi (formerly ascribed to Zygomycetes). A total of 26 mucoralean species can infect humans. Among these, the highest proportions of infections are caused by Rh [....] » Read More

Speaker at Infectious Diseases Conference - Waqar Ahmad
Oral Presentation (Virtual)
Waqar Ahmad, United Arab Emirates University, United Arab Emirates

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected more than 760 million people globally with over 6.8 million deaths to date due to COVID-19. Alteration of the host immune system upon infection can lead to multi-organ failure followed by critical patho [....] » Read More

Speaker at Infection Conferences - Mohammad Alshomrani
Oral Presentation (Virtual)
Mohammad Alshomrani, Riyadh Regional Laboratory and Blood Bank, Saudi Arabia

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has wreaked havoc on healthcare and economic systems worldwide. Despite extensive scientific research and efforts, there are still knowledge gaps regarding [....] » Read More

Speaker at Infectious Diseases Conferences - Kushal Kalvit
Oral Presentation (Virtual)
Kushal Kalvit, Tata Memorial Hospital, India

Introduction NORSE is an umbrella term with different aetiologies. The usual suspects are structural lesions, infections, toxins, metabolic causes, autoimmune or paraneoplastic encephalitis. Measles is a common infection that presents with a rash and is typically self-limiting. [....] » Read More

Speaker at Infection Conferences - Brandon Lucke-Wold
Oral Presentation (Virtual)
Brandon Lucke-Wold, Baylor University, United States

Background: Intracranial aneurysms (IAs) are more prevalent in women than men and aneurysmal subarachnoid hemorrhage disproportionately affects postmenopausal women. These sex differences suggest estrogen protects against IA progression that can lead to rupture, but the unde [....] » Read More

Speaker at Infection Conference - Victoria Belen Ayala Pena
Oral Presentation (Virtual)
Victoria Belen Ayala Pena, Departamento de Biología, Bioquímica y Farmacia-UNS, Argentina

Our interdisciplinary working group was motivated by the challenge of proposing tools for the fight against the sudden pandemic caused by SARS-CoV-2 in 2020 and the present. We have obtained several formulations based on chitosan, a biodegradable, non-antigenic, non-toxic, and bi [....] » Read More

Speaker at Infectious Diseases Conferences - Ranjan Ramasamy
Oral Presentation (Virtual)
Ranjan Ramasamy, IDFISH Technology, United States

Contrary to expectation, dengue incidence decreased in many countries during the period when stringent population movement restrictions were imposed to combat COVID-19. Using a Seasonal Autoregressive Integrated Moving Average model, we previously reported a 74% reducti [....] » Read More

Speaker at Infectious Diseases Conference - Agnes Nagy
Oral Presentation (Virtual)
Agnes Nagy, Hungarian Defence Forces Medical Centre, Hungary

Bacillus anthracis is the first ranked on the list of potential bioweapon agents. In case of biothreat emergency accurate and timely data resulted from on-site strain-level subtyping of the agent help to determine the origin of the used strain and provide the first bioforensic in [....] » Read More

Speaker at Infection Conferences - Fejiro Chinye-Nwoko
Oral Presentation (Virtual)
Fejiro Chinye-Nwoko, Nigeria Solidarity Support Fund, Nigeria

Background: Nigeria attested to the Abuja Declaration to allocate 15% of the annual budget to health. However, current allocation is about 4.7%. This left the country extremely vulnerable to the COVID-19 pandemic. As of December 2020, Nigeria had over 87,000 confirmed cases [....] » Read More

Speaker at Infectious Diseases Conference - Vladimir Zajac
Oral Presentation (Virtual)
Vladimir Zajac, Cancer Research Institute, Slovakia, Slovakia (Slovak Republic)

Every virus is a parasite that cannot exist on its own and is fully dependent on its carrier. This is the basic condition of its existence.  The parasite must have its host, and thus is a living cell.  Based on our long-term study of BLV and HIV, we conclude that the ca [....] » Read More

Speaker at Infection Conference - Isra Mufadal Abdulkareem Abdullah bur
Oral Presentation (Virtual)
Isra Mufadal Abdulkareem Abdullah bur, MBBS Gadarif University, Sudan

Background:  Even though respiratory viruses are one of the most common triggers for asthma exacerbations, not all of these viruses affect patients equally. Objective: To assess the prevalence of covid19 infection in patients presented with acute exacerbation of asthma, COP [....] » Read More

Speaker at Infection Conference - Ahlam Abdulsalam Albahloul Almabrouk
Oral Presentation (Virtual)
Ahlam Abdulsalam Albahloul Almabrouk, University of Gharyan, Libyan Arab Jamahiriya

Background: Cutaneous leishmaniasis (CL) is endemic in many regions of the world, and has a significant economic and health impacts. Despite the numerous proposed therapies for this zoonotic parasitic disease. Currently, there is no definitive cure for CL. Meglumine antimony comp [....] » Read More

Speaker at Infectious Diseases Conference - Jieming Qu
Oral Presentation (Virtual)
Jieming Qu, Shanghai Jiao Tong University School of Medicine, China

Introduction: The prevalence rate of SARS-CoV-2 Omicron variant infection reached approximately 80% in late 2022 in China. Tixagevimab/cilgavimab, a combination of two neutralizing monoclonal antibodies, showed significant efficacy for preventing COVID-19 in previous clinical tri [....] » Read More

Speaker at Infectious Diseases Conferences - Ivelina Trifonova Trionova
Poster Presentation (In-Person)
Ivelina Trifonova Trionova, National Centre of Infectious and Parasitic Diseases, Bulgaria

After a period of two seasons of absence (2020/2021) or low prevalence (2021/2022) of influenza viruses, the 2022-2023 season was characterized by high influenza activity in Bulgaria. The objectives of this study were to analyze the pattern of influenza virus circulation with res [....] » Read More

Speaker at Infectious Diseases Conferences - Aurelija Zvirbliene
Poster Presentation (In-Person)
Aurelija Zvirbliene, Vilnius University, Lithuania

Neisseria meningitidis causes invasive meningococcal disease (IMD), which is associated with significant mortality and long-term consequences, especially among young children. The incidence of IMD in Lithuania was among the highest in European countries during the past two decade [....] » Read More

Speaker at Infectious Diseases Conference - Kristina Cerniauskiene
Poster Presentation (In-Person)
Kristina Cerniauskiene, Lithuanian University of Health Science, Lithuania

Introduction: Acinetobacter baumannii (A. baumannii) is an important nosocomial pathogen that possesses not only intrinsic resistance to many classes of antibiotics, but also has a propensity for rapid development of antimicrobial resistance during treatment. Aims & O [....] » Read More

Speaker at Infectious Diseases Conference - Zsaklin Varga
Poster Presentation (In-Person)
Zsaklin Varga, University of Pecs, Hungary

The mosquito-borne pathogens are present worldwide, notable among these are Dirofilaria immitis, which causes heartworm disease, and Dirofilaria repens, known as the causative agent of subcutaneous dirofilariasis. These two species are unfortunately endemic throughout Europe and [....] » Read More

Speaker at Infectious Diseases Conference - Yuying Tang
Poster Presentation (In-Person)
Yuying Tang, Southeast University, China

Purpose : Dendritic cells (DCs) are always known as professional APCs which play a crucial role  in the link between innate and adaptive immunity. DCs can initiate both immunity and immunological tolerance , which means efficacy either in amelioration or exaggeration of infl [....] » Read More

Speaker at Infectious Diseases Conferences - Preeti Chaudhary
Poster Presentation (In-Person)
Preeti Chaudhary, Indian Council of Medical Research-NIMR, India

Malaria remains a global health issue affecting half of the world's population. The current treatment regimen which includes artemisinin and other combination therapies is being threatened with the rapid emergence of resistance. P. falciparum under drug pressure has revealed [....] » Read More

Speaker at Infectious Diseases Conference - Chansay Pathammavong
Poster Presentation (In-Person)
Chansay Pathammavong, National Immunization Program, Qatar

Objective: To eliminate measles and rubella, it is critical to develop strategic and efficient immunization programs. This study aimed to evaluate the population immunity and the measles-rubella program's effectiveness by estimating anti-measles and anti-rubella IgG prevalenc [....] » Read More

Speaker at Infection Conferences - Yuefeng Song
Poster Presentation (In-Person)
Yuefeng Song, Medical School of Nanjing University, China

Objective: To analyze the correlation between serological test results and oral clinical manifestations of patients with secondary syphilis, and to provide reference for clinical diagnosis and treatment. Methods: From January 2016 to December 2020, 30 patients with secondary [....] » Read More

Speaker at Infection Conferences - Wenmei Wang
Poster Presentation (In-Person)
Wenmei Wang, Medical School of Nanjing University, China

Objective: To evaluate the effect of a new anti-splash mask on preventing aerosol pollution in dental clinics. Methods: The aerosol distribution characteristics in different types of splash operations were analyzed in dental clinics at first. Different splash operations were [....] » Read More

Speaker at Infection Conferences - Mustafa AKIN
Poster Presentation (In-Person)
Mustafa AKIN, Petro Yağ ve Kimyasalları San. ve Tic. A.Ş., Turkey

Adjuvants were described as substances used in combination with a specific antigen that produced a more robust immune response than the antigen alone. There is an urgent need for the development of new and improved vaccine adjuvants. Infectious Bronchitis (IB) is one of the most [....] » Read More

Speaker at Infectious Diseases Conference - Marwah Saud Al-Thuhli
Poster Presentation (In-Person)
Marwah Saud Al-Thuhli, Oman Medical specialty Board, Oman

Objectives: Bloodstream infection (BSI) in children causes significant morbidity and mortality and is associated with longer hospital stays and higher healthcare costs. Our objective is to study the incidence and risk factors and identify causative organisms and outcomes of BSI a [....] » Read More

Speaker at Infectious Diseases Conference - Abdallah Musa Abdallah
Poster Presentation (In-Person)
Abdallah Musa Abdallah, Qatar University, Qatar

Metabolomics has been increasingly utilized in studying the host response to viral infections and for understanding the progression of multi-system disorders such as COVID-19. The analysis of metabolites in response to SARS-CoV-2 infection provides a snapshot of the end [....] » Read More

Speaker at Infectious Diseases Conference - Jernell Robert D Malixi
Poster Presentation (Virtual)
Jernell Robert D Malixi, Laguna Medical Center, Philippines

Background: Hospital Acquired Pneumonia is an important public health concern. Even with the advent of new anti-bacterials, there is an increasing prevalence of anti-microbial resistance worldwide. In particular, Ventilator Acquired Pneumonia can increase mortality risk in patie [....] » Read More

Speaker at Infection Conference - Houda Limam
Poster Presentation (Virtual)
Houda Limam, Faculty of Medicine of Tunis, Tunisia

Pseudomonas aeruginosa is an opportunistic pathogen, commonly causing hospital-acquired infections in burn patients. P. aeruginosa with difficult-to-treat resistance (DTR-PA) is resistant to all of the following: piperacillin-tazobactam, ceftazidime, cefepime, aztreonam, meropene [....] » Read More

Speaker at Infection Conferences - Khalid Abd-Elghany
Poster Presentation (Virtual)
Khalid Abd-Elghany, Egyption Drug Authority, Egypt

Klebsiella pneumoniae (K. pneumoniae) and Pseudomonas aeruginosa (P. Q25 aeruginosa) are the most common Gram-negative bacteria associated with pneumonia and coinfecting the same patient. Despite their high virulence, there is no effective vaccine against them. In the current stu [....] » Read More

Speaker at Infection Conference - Armin Mehmedovic
Poster Presentation (Virtual)
Armin Mehmedovic, University Hospital for Infectious Diseases, Croatia (Hrvatska)

Purpose: To evaluate the value of modified Brixia scoring system in predicting mortality in hospitalized COVID-19 patients. Methods and materials: An observational retrospective pilot study included 292 patients (178 male and 114 female) with PCR-confirmed COVID-19 infection h [....] » Read More

Speaker at Infectious Diseases Conferences - Rachida Belhadj Aissa
Poster Presentation (Virtual)
Rachida Belhadj Aissa, Public Hospital Establishment of Boufarik, Algeria

Background: Piringer Kuchinka’s lymphadenitis is a non-specific histological entity with multiple etiologies. We present an atypical case of visceral leishmaniasis in immunocompetent adult. A case report: 26-year-old male student in perfect health, living in an urban area [....] » Read More

Speaker at Infectious Diseases Conference - Cintia Gisela Cevallos
Poster Presentation (Virtual)
Cintia Gisela Cevallos, University of Buenos Aires INBIRS, Argentina

Background. The novel coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2 is severe and involves multiple organs in approximately 5%-10% of patients, leading to multi-organ dysfunction and failure. Methods. Necropsy tissues (lungs, heart, liver, kidney, small-intestine) we [....] » Read More

Speaker at Infectious Diseases Conferences - Emmanuel Boafo
Poster Presentation (Virtual)
Emmanuel Boafo, University of Ghana, Ghana

Ticks are second to mosquitoes in disease transmission yet, significant gaps remain in our knowledge of how ticks transmit pathogens to wild animals and even humans. According to the one-health concept, wild ticks may contribute to the transmission of tick-borne diseases such as [....] » Read More

Speaker at Infection Conference - Houda Limam
Poster Presentation (Virtual)
Houda Limam, Faculty of Medicine of Tunis, Tunisia

Background : Brucellosis is a common bacterial zoonotic disease with a broad spectrum of clinical manifestations. Osteoarticular involvement is frequent, with a reported prevalence ranging from 27% in nonendemic regions to 36% in endemic regions. The sacroiliac and spinal joints [....] » Read More

Speaker at Infectious Diseases Conferences - Rachida Belhadj Aissa
Poster Presentation (Virtual)
Rachida Belhadj Aissa, Public Hospital Establishment of Boufarik, Algeria

Cryptococcosis is a fungal potentially fatal infection, especially in its meningeal location. It’s most often due to Cryptococcus neoformans (Cn). Cellular immunosuppression, in particular the advanced stage of HIV infection, is a frequent risk factor for the onse [....] » Read More

Watsapp